lobbying_activities: 3385077

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3385077	6dbc12f3-f7ac-4870-a95a-ba86f2336f54	Q2	ALB SOLUTIONS	401105973	BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.	2025	second_quarter	PHA	Issues related to regulatory and legislative developments regarding biosimilars and prescription digital therapeutics.	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2025-07-16T13:16:12-04:00